Vitro Corporation of America v. Hall Chemical Company, and James D. Hall

292 F.2d 678, 131 U.S.P.Q. (BNA) 90
CourtCourt of Appeals for the Sixth Circuit
DecidedAugust 9, 1961
Docket14328
StatusPublished
Cited by22 cases

This text of 292 F.2d 678 (Vitro Corporation of America v. Hall Chemical Company, and James D. Hall) is published on Counsel Stack Legal Research, covering Court of Appeals for the Sixth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Vitro Corporation of America v. Hall Chemical Company, and James D. Hall, 292 F.2d 678, 131 U.S.P.Q. (BNA) 90 (6th Cir. 1961).

Opinion

SIMONS, Senior Judge.

This appeal involves an accounting for damages arising out of a breach of a nondisclosure agreement by the appellant, Vitro Corporation of America (hereinafter referred to as Vitro), which it had entered into with the appellees, The Hall Chemical Company and James D. Hall, (hereinafter referred to as Hall). Previously, in an interlocutory appeal, we had affirmed a determination by the District Court that Vitro had breached its agreement. 6 Cir., 254 F.2d 787 (April 19, 1958). After our interlocutory decision, the District Court referred the determination of damages to a special master who made findings of fact and announced conclusions of law and recommended that Hall be awarded damages in the amount of $348,699.00, plus interest. The District Court overruled all of Vitro’s exceptions and confirmed the master’s findings and conclusions, granting, however, Hall’s lone exception to the master’s report which objected to the determination that no damages should be awarded for the portion of the year 1958 to the date of our mandate, May 14, 1958. Accordingly, an additional $18,493.03 damages were assessed against Vitro. Also various costs and expenses were taxed against Vitro.

Much of the factual background of this case is set forth in our earlier opinion. Certain facts not therein recited or later developed in the accounting proceedings have relevance to damages and must be considered. The events upon which this litigation rests began in 1953. Vitro, for several years, had been engaged in the recovery of metal salts by hydro-metallurgical processes. It owned several plants, one of which was a refining plant at Canonsburg, Pa., which had been utilized for reclamation of uranium from atomic wastes, obtained primarily pursuant to a contract with the Atomic Energy Commission. In August, 1953, Vitro learned that its contract with the AEC might not be renewed. Thus, it became necessary for Vitro to find other uses for the Canonsburg plant. Among possibilities it considered was recovery of metal salts from high temperature steel alloy scrap, notably S-816 used in jet engines which was available in some quantity in the period following the Korean War, in 1953. Vitro did not know of any commercially feasible method for the recovery of the valuable components of the scrap, principally, cobalt, nickel and chromium. Summers, its chemist, indicated that two problems made reclamation of the valuable metals impractical from a commercial standpoint. They were lack of an economical digestion method which would quickly dissolve large chunks of scrap and after dissolution is achieved, the difficulty of separating cobalt from other metals since cobalt, the most valuable element, would be contaminated by chromium.

Vitro embarked upon various laboratory experimentation to develop a commercially useful reclamation process without appreciable success. However, it learned from a high official in the Defense Department that Hall had developed a practical reclamation process. Thereupon, it made contact with James D. Hall *680 and negotiations were commenced concerning a contemplated purchase of the process by Vitro.

Thus, on September 17, 1953, various people from Vitro were taken through the Hall plant at Wickliffe, Ohio, for a period of approximately three hours. On that day, Hall took the Vitro representatives through the building, showed them his equipment and made certain explanations. On October 13th and 14th, Hall, his attorney and the accountant came to New York and conferred with Vitro for the purpose of making a business arrangement for Vitro’s use of the Hall process. At these meetings, Vitro asked to be allowed to make an extensive study of the Hall process and to have the details of the process disclosed to it. It was suggested by Hall’s lawyer that the parties enter into a non-disclosure agreement, the breach whereof is the subject matter of this litigation. An agreement was executed on October 21, 1953 which reads as follows: “So that you and representatives of your company and ours may discuss technical information which you have available as to scrap metal recovery processes, presently in commercial use by The Hall Chemical Company, confidential and secret in nature, we agree, in consideration of disclosures to us of such technical and operative information relating to scrap metal recovery processes, to keep confidential the information so imparted to us and not to make use of it until it becomes publicly known other than by an act or omission on our part.”

Also, at the New York meeting in October, Hall and representatives of Vitro commenced discussion of a proposed agreement for the use by Vitro of the Hall process and thereafter “agreed in principle” on the terms of the proposed arrangement subject to Vitro’s confirmation and study of several technical matters. The substance of the “agreement in principle” as indicated by the evidence, including the minutes of Vitro’s executive committee meeting on October 16,1953, is as follows: Vitro would pay $100,000.00 on execution of the agreement, a minimum payment of $50,000.00 per year for a period of six years, with maximum payment of $1,500,000.00. While the cross complaint recited terms for patent infringement these were later withdrawn.

Following the formulation of the “agreement in principle” and the execution of the non-disclosure agreement, Vitro’s chemists spent approximately one week at Hall’s Wickliffe plant where Hall fully disclosed his process for the recovery of metal salts from S-816 scrap, including both the digestion step and the separation of various metals in solution from each other.

At the November 4, 1953 meeting of the Board of Directors of Vitro, both agreements were reported by George White, Vitro’s Executive Vice President, who had signed the non-disclosure agreement in its behalf. The minutes of the board meeting show that White reported to the Board on the status of the negotiations with Hall for the acquisition of his patent pertaining to the recovery of cobalt, nickel, columbium, molybdenum, etc., reviewed his professional background and experience, the nature of the process for which he claimed to hold patents, and the scope of his current operations, and that Hall had originally asked $1,500,000.00 for his patent. White also reported that although it is recognized that the payments to Mr. Hall are relatively high, it is the opinion of Management that this should be a very profitable business in a field where considerable work is needed, and is beginning at a time when we have an empty plant at Canonsburg requiring work. The Management will continue their investigation into all possible details and hopes to have a complete proposal ready for presentation to the Board at its next meeting.

Thus, the status of the negotiations between Hall and Vitro, as indicated by Vitro’s own records, as of November 4, 1953, was that a non-disclosure agreement had been executed pursuant to which Hall had made full disclosures to Vitro and that while no firm agreement had been consummated concerning payments to Hall for his process, the parties nonethe *681 less had, after some measure of bargaining, settled upon a definite price scheme, the minimum amounts being a $100,-000.00 initial payment and $50,000.00 per annum for a period of six years.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Adcor Industries v. Beretta U.S.A.
248 A.3d 1137 (Court of Special Appeals of Maryland, 2021)
Calce v. Dorado Exploration, Inc.
309 S.W.3d 719 (Court of Appeals of Texas, 2010)
Vermont Microsystems, Inc. v. Autodesk, Inc.
88 F.3d 142 (Second Circuit, 1996)
American Sales Corp. v. Adventure Travel, Inc.
862 F. Supp. 1476 (E.D. Virginia, 1994)
United States v. Inslaw, Inc. (Inslaw, Inc.)
36 Cont. Cas. Fed. 75,765 (District of Columbia, 1989)
Biodynamic Technologies, Inc. v. Chattanooga Corp.
658 F. Supp. 266 (S.D. Florida, 1987)
University Computing Co. v. Lykes-Youngstown Corp.
504 F.2d 518 (Fifth Circuit, 1974)
Elcor Chemical Corp. v. Agri-Sul, Inc.
494 S.W.2d 204 (Court of Appeals of Texas, 1973)
Forest Laboratories, Inc. v. Formulations, Inc.
320 F. Supp. 211 (E.D. Wisconsin, 1970)

Cite This Page — Counsel Stack

Bluebook (online)
292 F.2d 678, 131 U.S.P.Q. (BNA) 90, Counsel Stack Legal Research, https://law.counselstack.com/opinion/vitro-corporation-of-america-v-hall-chemical-company-and-james-d-hall-ca6-1961.